Accessibility Menu
 
Repligen logo

Repligen

(NASDAQ) RGEN

Current Price$116.30
Market Cap$6.55B
Since IPO (1986)+1,035%
5 Year-38%
1 Year-17%
1 Month-14%

Repligen Financials at a Glance

Market Cap

$6.55B

Revenue (TTM)

$738.26M

Net Income (TTM)

$48.89M

EPS (TTM)

$0.86

P/E Ratio

134.60

Dividend

$0.00

Beta (Volatility)

1.45 (Average)

Price

$116.30

Volume

19,194

Open

$115.30

Previous Close

$116.30

Daily Range

$114.55 - $117.68

52-Week Range

$102.97 - $175.77

RGEN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Repligen

Industry

Life Sciences Tools and Services

Employees

2,000

CEO

Olivier Dominique Loeillot, MBA

Headquarters

Waltham, MA 02453, US

RGEN Financials

Key Financial Metrics (TTM)

Gross Margin

51%

Operating Margin

8%

Net Income Margin

7%

Return on Equity

2%

Return on Capital

2%

Return on Assets

2%

Earnings Yield

0.74%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.55B

Shares Outstanding

56.33M

Volume

19.19K

Short Interest

0.00%

Avg. Volume

780.21K

Financials (TTM)

Gross Profit

$347.62M

Operating Income

$59.58M

EBITDA

$164.30M

Operating Cash Flow

$117.42M

Capital Expenditure

$23.52M

Free Cash Flow

$93.90M

Cash & ST Invst.

$767.63M

Total Debt

$689.95M

Repligen Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$197.91M

+18.1%

Gross Profit

$93.44M

+140.6%

Gross Margin

47.21%

N/A

Market Cap

$6.55B

N/A

Market Cap/Employee

$3.69M

N/A

Employees

1,778

N/A

Net Income

$13.29M

+139.2%

EBITDA

$44.98M

+2031.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$77.68M

+9.2%

Accounts Receivable

$158.59M

+18.2%

Inventory

$170.46M

+19.2%

Long Term Debt

$668.39M

-0.4%

Short Term Debt

$21.56M

+42.7%

Return on Assets

1.66%

N/A

Return on Invested Capital

1.98%

N/A

Free Cash Flow

$17.05M

-47.0%

Operating Cash Flow

$25.70M

-34.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BIOBio-Rad Laboratories, Inc.
$271.94+2.62%
AVTRAvantor, Inc.
$7.72+1.78%
CRLCharles River Laboratories International, Inc.
$159.25+0.79%
ATRAptarGroup, Inc.
$124.16+0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.61+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.80-0.02%
IBRXImmunityBio
$7.41-0.21%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.02%

Questions About RGEN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.